Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission [Phase 2]
Phase 2 clinical trial update evaluating bortezomib for high-risk acute myeloid leukemia in remission; the study was terminated with results…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluating chemosensitization with plerixafor plus G-CSF in acute myeloid leukemia has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML [Phase 1, Phase 2]
This clinical trial update covers high-dose donor hematopoietic stem cell infusion being evaluated for relapsed or refractory acute myeloid …
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS [Phase 2]
Phase 2 clinical trial evaluated a sequence of decitabine followed by idarubicin and cytarabine in adults with relapsed or refractory acute …
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [NA]
A terminated clinical trial evaluated mobilizing donor peripheral blood stem cells with plerixafor and filgrastim before donor transplant in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies [Phase 1]
Phase 1 clinical trial update describing safety assessments for two infusion schedules of SNS-595 in patients with hematologic malignancies.…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Trial of Pimasertib in Hematological Malignancies [Phase 2]
Phase 2 trial of pimasertib in acute myeloid leukemia and other hematologic neoplasms was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating an investigational biological therapy in adults with advanced mye…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations [Phase 1]
Phase 1 trial evaluating the combination of filgrastim, plerixafor, and sorafenib in FLT3-mutated acute myeloid leukemia; the study has comp…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant [Phase 1]
Phase 1 results evaluating sorafenib as maintenance therapy in patients with acute myeloid leukemia after allogeneic stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment [NA]
Clinical trial results posted on using hyperbaric oxygen therapy to improve umbilical cord blood stem cell homing and engraftment in patient…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission [Phase 2]
Phase 2 clinical trial evaluating reduced intensity donor peripheral blood stem cell transplantation in patients with de novo or secondary a…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies [Phase 2]
Phase 2 trial evaluating alemtuzumab, fludarabine phosphate, and low-dose total body irradiation as a conditioning regimen before donor stem…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) [Phase 3]
This Phase 3 trial comparing posaconazole prophylaxis against standard azole therapy in neutropenic patients has completed. It includes pati…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update of ixazomib in relapsed or refractory acute myeloid leukemia has been terminated; results were posted previous…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML [Phase 1, Phase 2]
Phase 1/2 trial evaluating arsenic trioxide in combination with cytarabine for high-risk myelodysplastic syndrome and poor-prognosis acute m…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation in young patients with acute myeloid leukemia, including cases with mono…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia [Phase 1]
Phase 1 trial evaluating low-dose total-body irradiation and fludarabine phosphate followed by an unrelated donor stem cell transplant in pa…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant [Phase 2]
Phase 2 trial of T-cell replete haploidentical donor hematopoietic stem cell transplantation with natural killer (NK) cell support in hemato…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Alisertib for Acute Myeloid Leukemia [Phase 1]
Phase 1 trial of alisertib for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating the combination of tosedostat with cytarabine or decitabine in adults with newly diagnosed acute myeloid leukemia o…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients [NA]
A clinical trial examining reflexology as an intervention for patients with Acute Myeloid Leukemia.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia [Phase 2]
A prospective Phase 2 interventional trial evaluating response to the ADE regimen (cytarabine, daunorubicin, and etoposide) for first relaps…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating therapeutic allogeneic lymphocytes with aldesleukin for high-risk or recur…